 |
For ongoing studies, KAI staff members:
- create source documents, forms, manual of operations;
- conduct training;
- provide electronic CRF data management system
quality control, safety reporting, and final report.
ONGOING or RECENT AREAS of STUDY SUPPORT
Ongoing or recent industry studies that benefit from KAI
support include treatment studies in the following disease
and research areas:
 |
 |
 |
 |
pain |
lupus |
| |
stroke |
sepsis |
| |
diabetes |
head injury |
| |
depression |
osteoporosis |
| |
insomnia |
interstitial cystitis |
| |
substance abuse |
vascular dementia |
| |
myasthenia gravis |
Desert Storm syndrome |
| |
Parkinson's
disease |
anesthetic agents |
| |
Alzheimer's
disease |
oncologic biomarkers |
| |
rheumatoid arthritis |
vaccine effectiveness |
| |
multiple sclerosis |
|
NIH SUPPORT
KAI is also supporting over a dozen studies for treatment of substance
abuse for the National Institute on Drug Abuse (NIDA) and
several clinical studies for the National Institute of Mental
Health (NIMH). In addition, KAI provides quality assurance for
clinical trials funded by the National Institute of Arthritis,
Musculoskeletal and Skin (NIAMS) and the National Institute
of Neurological Disorders and Stroke (NINDS).
Of interest, KAI's support of the NIH Pediatric
Pharmacology Research Units (PPRU) makes us particularly
qualified to conduct pediatric studies.
|
|